Does Modafinil Show Up on a Drug Test? UK Guide (2026)

Last updated: October 2026. This guide is general information, not medical advice.

The short answer

Modafinil is not one of the substances that standard workplace urine panels are designed to detect, and panel composition varies by country, provider and employer policy. The US federal drug categories include amphetamines, cocaine, cannabis, opiates/opioids (with fentanyl now included) and phencyclidine. Modafinil is structurally different from amphetamine and is not on the standard target lists.

But there are three important caveats.

The three caveats

Immunoassay screens are approximations. A positive result on a screening immunoassay is a preliminary finding, not a confirmed identification. Confirmatory laboratory methods (GC-MS or LC-MS/MS) distinguish between molecules definitively – if a screen flags, the confirmatory run is the arbiter, and what any confirmatory panel covers is decided by the testing body.
Specialised testing can target it. Sports testing does: modafinil sits under the World Anti-Doping Agency’s S6 stimulant category, prohibited in competition. Whether any employer tests for it specifically depends on their panel.
Prescription disclosure exists for this situation. Follow the testing programme’s confidential medication-disclosure process, which may involve a Medical Review Officer or occupational health. The exact process and protection depend on the employer’s policy and the testing framework, so the safe course is to disclose rather than assume.

Detection windows (with the honest uncertainty)

Reliable, population-level detection windows for modafinil are scarce. A small published excretion study reported detection of parent modafinil in urine up to about 80 hours under its test conditions; that cannot be read as a universal clearance window. The parent drug’s effective half-life after multiple doses is around 15 hours, and detection depends on dose, test sensitivity and individual metabolism. Treat any specific day-count you read elsewhere with the same scepticism.

What workplace panels actually screen for

Standard panels are built around drugs of abuse, not prescription wakefulness medicines. For any specific workplace test, the panel list itself is the ground truth.

Practical guidance

If you have a prescription: follow the testing programme’s disclosure process, which may involve a Medical Review Officer or occupational health; the details depend on your employer’s policy.
If you do not have a prescription: the standard panels do not target modafinil, but specialised or confirmatory testing can identify it when the method includes modafinil. There is no legitimate method to alter a test result, and trying is a serious matter in any employment context.
Athletes: modafinil is WADA-prohibited in competition. Check GlobalDRO or your governing body before taking anything – status can change between list revisions.

Common questions

Will modafinil make me fail a drugs test for work? On standard 5- or 10-panel screens, modafinil is not a target compound, and any screening flag should be resolved by the confirmatory testing process. Nobody can honestly guarantee any individual result – the panel list and the testing body’s confirmatory process decide.

How long does modafinil stay in your system? A small published excretion study reported detection of parent modafinil in urine up to about 80 hours under its test conditions. The effective half-life after multiple doses is around 15 hours; individual variation is real.

Do employers test for modafinil specifically? Standard workplace screening panels do not target it. Sports testing does (WADA S6.A, prohibited in competition); whether any other programme does depends on that programme’s panel.

Is modafinil a controlled drug in the UK? Modafinil is a prescription-only medicine (POM) in the UK; it is not a scheduled controlled drug under the Misuse of Drugs Regulations. Employment policies can still restrict it independently. Our legality guide covers the position in detail.